Entrada Therapeutics' Series A Round

Entrada Therapeutics raised a round of funding on December 18, 2018.

Entrada Therapeutics aims to treat devastating diseases through the intracellular delivery of biologics. Entrada's technology enables the efficient intracellular delivery of proteins, peptides and nuc…

Articles about Entrada Therapeutics' Series A Round: